02.12.2020 16:17:59
|
Stock Alert: Reata Pharmaceuticals Falls 10%
(RTTNews) - Shares of clinical-stage biopharmaceutical company Reata Pharmaceuticals, Inc. (RETA) are falling more than 10% Wednesday morning at $136.53.
Tuesday, the company said it priced the proposed public offering of 2 million shares of its Class A common stock at $140.85 per share pursuant to an existing shelf registration statement.
Reata intends to grant the underwriters a 30-day option to purchase 300,000 additional shares of its Class A common stock.
RETA has been trading in the range of $88.17- $257.96 in the last one year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Reata Pharmaceuticals Inc (A)mehr Nachrichten
Keine Nachrichten verfügbar. |